2019 Cannabis Business Award's Publication of the Year |
FLORIDA SUPREME COURT SAYS YES!! |
FMCPG HAS BEEN SERVING AND REPRESENTING THE CANNABIS PHYSICIAN COMMUNITY SINCE 2020 |
THE
"FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP"
(FMCPG) FOR ALL
"MEDICAL MARIJUANA DOCTORS"
AND "MMTC DIRECTORS ONLY " DISCUSSION WILL INCLUDED:
RESULTS OF SURVEY
REVIEW OF THE OMMU AND CHANGES TO THE DOCTOR'S PATIENT INPUT PORTAL ON THE OMMU WEBSITE.
DOCTORS WITHIN OUR GROUP WILL DISCUSS HOW THEY HAVE BEEN WORKING AROUND SOME OF THE CHANGES
LEGISLATIVE AGENDA FOR 2024 -2025
REF'S ISSUES AND SOLUTIONS
CLICK HERE TO REGISTER FOR THE JULY 24, 2024 MEETING |
MEDICAL CANNABIS PHYSICIAN PROMOTION PACKAGE BY
CANNABIS NEWS FLORIDA ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks). E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast. The cost of this program is ONLY $500.
**Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.
IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785 |
NEWS FROM THE PAST WEEK
RELATING TO THE BUSINESS OF MMTC'S
IN FLORIDA Click on Company Logo to be Transferred to Web Site
|
THE CANNABIST COMPANY CELEBRATES GROWING OLD PAL PARTNERSHIP WITH BRAND LAUNCH IN NEW JERSEY AND EXPANDED PRODUCT OFFERINGS IN MARYLAND AND VIRGINIA
Collaboration Serves Increased Demand in Growing East Coast Markets
NEW YORK –July 18, 2024– The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today the expansion of its partnership with Old Pal, a top-performing lifestyle cannabis brand, into New Jersey with new/additional products launching in Maryland and Virginia.
The Cannabist Company recently launched Old Pal classic and infused blunts; 2-pack pre-rolls; and its signature 7g Ready to Roll kit in New Jersey. The Ready to Roll kit features classic pre-ground cannabis, rolling papers, and crutches, packaged into a resealable pouch, offering consumers everything they need to roll a joint and elevate any moment, anywhere. The products are available at Cannabist locations in Vineland and Deptford and available across its wholesale channels throughout New Jersey.
READ MORE |
PLANET 13 ANNOUNCES LAUNCH OF NEW LIFESTYLES BRAND COMPANY WITH SIGNING OF FIRST SPONSORED ATHLETE, UFC TITLE CONTENDER CHITO VERA
THE UFC’S #4 RANKED BANTAMWEIGHT CONTENDER WILL PROMOTE PLANET 13 FIGHT CLUB, THE COMPANY’S COMBAT SPORTS THEMED DIVISION OF ITS NEW PLANET 13 LIFESTYLES BRAND
LAS VEGAS, July 24, 2024 — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced the launch of its non-cannabis touching Lifestyles brand company, and its first sponsored athlete, MMA star Chito Vera. The timing couldn’t be better with Chito scheduled to fight live nationally on ABC TV at UFC Abu Dhabi on August 3, 2024. A win in this fight for the Ecuadorian UFC star could lead to a title shot.
“Chito Vera is the perfect fit for Planet 13 and our new Lifestyles brand,” said Larry Scheffler, Planet 13 Co-CEO. “He’s a dynamic cross-over star with a wide demographic reach that touches much of Planet 13’s existing fan base. Vera is currently the UFC #4 ranked title contender, a household name for any fight fan, an adrenaline junkie with ties to the X-Games, a fashion and classic car guru, and with Chito you can expect to get 110% every time. We’re extremely excited for this new partnership and what’s to come with Chito and Planet 13 Fight Club, the combat sports division of our Planet 13 Lifestyles brand.”
READ MORE |
VIRIDIAN CHART OF THE WEEK: AN EARLY LOOK AT UPCOMING Q2:2024 EARNINGS FOR MSOS
Viridian’s Chart of the Week previews the upcoming Q2:2024 earnings releases for MSOs that begin in the first week of August. We wanted to have an early look before the company nudging of analysts “corrects” the estimates. The table below shows consensus estimates of Q2:2024 revenues and EBITDA for 14 MSOs in order of release date. Revenues for Q1:24 and Q2:23 are presented for comparison purposes.
Half of the companies on the chart have projected negative sequential growth in EBITDA for Q2:24. This is surprising because Q2 is generally a seasonally stronger quarter, and in the previous three years, an average of nearly 80% of the companies on the chart have had higher EBITDA in Q2 compared to Q1.
Analysts are projecting a 10.2% y/o/y EBITDA growth for Q2 and full-year 2024 EBITDA growth of 9.8% compared to 2023. However, 1st half of 2024 results, including the Q2 estimates, are 14.2% higher than the 1st half of 2023, implying that second-half growth will only be around 6.0%. Are analysts expecting dramatic slowing, or have they just not updated their 2024 estimates?
Anecdotally, IR spokesmen for several companies have spoken of tightening consumer spending, price declines in New Jersey and other markets, and a generally competitive retail environment.
READ MORE |
CANNABIS LAW ANNOUNCES TRANSITION INTO LUMALEX LAW, A FULL-SERVICE LAW FIRM SERVING EMERGING AND HIGHLY REGULATED INDUSTRIES
Mr. Cannabis Law Now Serves as a Consulting Firm that Provides Various Non-legal Services for the Cannabis Industry
Fort Lauderdale, FL — July 15, 2024 – Mr. Cannabis Law is pleased to announce the rebrand of its law firm into LumaLex Law, a full-service law firm serving clients in emerging and highly regulated industries, such as cannabis, psychedelics, alternative health, artificial intelligence (AI), health clinics, ketamine clinics, real estate, technology and more.
LumaLex Law was founded with one guiding principle: a law firm should aim to be a profit center for its clients, not a cost center. LumaLex Law’s Founding Partner Dustin Robinson is an attorney, CPA, investment fund manager, licensed real estate agent and experienced entrepreneur who has founded multiple start-ups. LumaLex Law was established to bring this unique skill set to founders and business leaders of early-to-growth stage companies who need a law firm that treats their business like an investment, not simply a source of billable hours.
Emerging industries require intuitive and experienced lawyers due to their unique regulatory challenges, complex contractual needs and intensive intellectual property considerations. With deep industry knowledge, LumaLex Law navigates emerging regulatory landscapes, mitigates legal risks and drafts tailored contracts that protect clients’ interests as their business grows.
READ MORE |
NATIONAL AND INTERNATIONAL NEWS |
TILRAY MEDICAL GRANTED APPROVAL TO INTRODUCE THIRD MEDICAL CANNABIS PRODUCT IN PORTUGAL TILRAY’S SOLUÇÃO ORAL THC10:CBD10 MEDICAL CANNABIS EXTRACT IS NOW APPROVED FOR MEDICAL USE IN PORTUGAL
CANTANHEDE, Portugal, July 24, 2024 — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced another milestone achievement in medical cannabis in Europe. Following the successful approval of Tilray Medical whole flower THC 18, and approval for the first cannabis extract in Portugal earlier this year, Tilray Medical receives its second approval for a new medical cannabis extract in Portugal: Tilray Oral Solution THC10:CBD10, also known as Tilray Solução Oral THC10:CBD10.
READ MORE |
TILRAY RECEIVES FIRST NEW CANNABIS CULTIVATION LICENSE IN GERMANY UNDER NEW REGULATIONS
Tilray’s Aphria RX Facility in Germany Granted New Cannabis Cultivation License, Allowing for ~5x Production Increase and New Strains to Enhance Patient Access Across the Country
Aphria RX Designed with Guidance from Renowned Cannabis Grower of Broken Coast Cannabis
NEUMÜNSTER, Germany, July 22, 2024 — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced that its Germany cannabis cultivation facility, Aphria RX GmbH (“Aphria RX”), has received the first new cannabis cultivation license issued under MedCanG, Germany’s new Cannabis Act. The new cannabis cultivation license allows Aphria RX to cultivate and manufacture a broad commercial range of medical cannabis, providing patients with better access to high-quality medical cannabis produced in Germany.
Tilray’s Chief Strategy Officer and Head of International, Denise Faltischek, commented: “We are thrilled to receive this license as it will provide greater access to some of the highest quality medical cannabis produced in Germany and enable us to expand the range of treatment options available to patients. We appreciate the trust that the German Government has placed in Tilray, and we are proud of our team for their groundbreaking work in medical cannabis cultivation and patient care.”
READ MORE |
SUN THEORY HOLDING CO. TAPS TOP INDUSTRY EXECUTIVE ICONS TO LEAD A RETAIL AND SALES REVOLUTION IN THE CANNABIS INDUSTRY
New VP of Retail Blythe Huestis and VP of Sales Kevin Schultz bring more than two decades of industry experience to the rapidly expanding Sun Theory portfolio of companies
DENVER, July 17, 2024 — Sun Theory Holding Co., a leading vertically integrated cannabis operator, today announced it has appointed cannabis industry veterans Blythe Huestis as VP of Retail and Kevin Schultz to the role of VP of Sales. The two newly created positions will provide critical strategic guidance as Sun Theory continues to support the growth of its existing portfolio companies, identify new acquisitions and position the company for national expansion. Both Huestis and Schultz will report directly to Sun Theory Chief Executive Officer Connor Oman.
“At this important time in our evolution, we are building a dream team that will accelerate the company’s growth and expansion in all the ways that matter,” Oman said. “Possessing more than two decades of industry expertise, both Blythe and Kevin are excited to help continue the legacy of industry champion brands like Terrapin Care Station and Dialed In Gummies. We are so proud of all our portfolio companies, their commitment to both their legacy and the future, as well as the company’s overall strategic trajectory.”
READ MORE |
MANITOBA HARVEST HEMP FOODS AND BRIGHTSEED® INTRODUCE NEW COFFEE AND CHOCOLATE FLAVORS IN ORGANIC BIOACTIVE FIBER SUPPLEMENT FOR GUT HEALTH
Lighten up with Bioactive Fiber! Manitoba Harvest and Brightseed unveil new products and research in support of digestive and metabolic health
NEW YORK and WINNIPEG, Manitoba, July 17, 2024 — Manitoba Harvest, the global leader in hemp foods and a wholly-owned subsidiary of Tilray Brands, Inc. (“Tilray” or the “Company”) (NASDAQ: TLRY and TSX: TLRY), announced its second series of its proprietary and revolutionary Organic Bioactive Fiber in partnership with Brightseed®, the bioactives company on a mission to illuminate nature to restore human health. Unveiling two new flavors —Coffee and Chocolate—the new products are intended to elevate the fiber experience for gut wellness and healthy digestion.
Manitoba Harvest's trio of BioActive Fiber Now Available
Manitoba Harvest Bioactive Fiber harnesses the total nutritional profile of organic hemp fiber for digestive wellness, and is powered by Brightseed® Bio Gut Fiber, made from upcycled hemp hulls, the outer shells of hemp seeds which contains two unique bioactives to support gut health. With benefits ranging from promoting a healthy gut to supporting regularity and prolonged satiety, these products are a game-changer for consumers seeking new and exciting solutions to meet their daily fiber requirements.
READ MORE |
MARIMED COMMENCES OPERATIONS IN NEWLY EXPANDED AREA OF MARYLAND CULTIVATION FACILITY
SEEDLINGS PLANED IN NEW GROW ROOMS, IN TIME FOR RETAIL AND WHOLESALE DISTRIBUTION OF PRODUCTS DURING FOURTH QUARTER OF 2024
NORWOOD, Mass., July 22, 2024 — MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it recently commenced operations in the newly expanded area of its cultivation and processing facility in Hagerstown, Maryland. The expansion will double the facility’s flower capacity, enabling MariMed to meet the growing demand for its flower, concentrates, and edibles products in the state.
MariMed is on track to fill all nine new grow rooms with new plantings over the next two months. The Company anticipates its first harvest will be ready for sale through both retail and wholesale channels during the fourth quarter of this year.
“We are thrilled to announce the commencement of cultivation operations in the new wing of our cultivation facility in Hagerstown,” said Jon Levine, MariMed’s Chief Executive Officer. “Maryland is a fantastic, high-growth, adult-use market. Increasing flower production capacity in Maryland was one of our strategic priorities and was necessary to meet the growing demand for our products throughout the state.”
READ MORE |
CHAIN BRIDGE I TO ACQUIRE PHYTANIX BIO, CREATING A NEW PUBLIC COMPANY FOCUSED ON DEVELOPING NEXT GENERATION CANNABINOID AND CANNABINOID-LIKE MEDICINES
Phytanix Bio is a preclinical stage pharmaceutical company founded by former members and associates of GW Pharmaceuticals, holding exclusive cannabinoid and cannabinoid-like medicine intellectual property (IP)
The transaction reflects a pre-deal valuation of $58 million for Phytanix Bio plus the assumption of $17 million of preferred stock and $4.4 million of short-term debt that will be exchanged for convertible preferred stock at deal close
The business combination is expected to be completed in the fourth quarter of 2024, with the combined company to be listed on Nasdaq Capital Markets under the ticker “PHYX”
NEW YORK and SANTA BARBARA, Calif., July 22, 2024 — Phytanix Bio, an innovative pharmaceutical company dedicated to the development of therapeutics based on cannabinoid and cannabinoid-like molecules, and Chain Bridge I (Nasdaq: CBRG) (“CBRG”), a special purpose acquisition company formed for the purpose of acquiring or merging with one or more businesses, today announced they have entered into a definitive business combination agreement. Upon closing of the transaction, expected to occur in the fourth quarter of 2024, the combined company will be named Phytanix Inc., and its common stock is expected to be listed on the Nasdaq Capital Market under the ticker symbol “PHYX.”
The new company will be led by Phytanix Bio’s founders Colin Stott, the former R&D operations director at GW Pharmaceuticals; Dominic Schiller, who formerly led GW’s external IP strategy for more than a decade; and Barrett Evans, managing director at EMC2 Capital.
Mr. Evans will serve as CEO of the combined company; Mr. Stott will serve as chief operating officer; and Mr. Schiller will lead the legal and IP strategy. Guy Webber, a former GW preclinical team member and world-leading expert in cannabinoids/drug metabolism, will lead preclinical development for the organization.
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND
DISPENSARIES IN THE STATE OF FLORIDA |
QUALIFIED PATIENTS
OVER 884,000
AND 657 DISPENSING LOCATIONS |
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
JULY 19, 2024 Report BY THE NUMBERS
Qualified Patients: (Active ID Card) JUL 19 2024- 884,844
JUL 12 2024- 884,531
JUL 05 2024 881,780
JUN 28 2024- 883,567
JUN 21 2024- 883,375
JUN 14 2024- 882,933
Pattients Last Week: 313
Qualified Ordering Physicians: 2,293
New Doctors Last Week: 12 Reporting Period: JULY 12 TO JULY 18, 2024
Amount of Medical Marijuana Dispensed - (mgs THC) 322,618,677
Amount of Low-THC Cannabis Dispensed - (mgs CBD) 3,126,509
Amount of Marijuana in a From for Smoking (oz) 112,484.919
Approved Dispensing Locations: 657
ADD LAST WEEK : 1
TRULIEVE |
UPCOMING MEETING AND CONFERENCES |
2024 Florida Cannabis Festival November 2nd and 3rd |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|